Severe central nervous system involvement in juvenile dermatomyositis

Journal of Rheumatology

Volumn 30, Issue 9, 2003, Pages 2059-2063

  Elst, Elisabeth F ^a   Kamphuis, Sylvia S M ^b   Prakken, Berent J ^b   Wulffraat, Nicolas M ^b   Van der Net, Janjaap ^b   Peters, A C Boudewyn ^b   Kuis, Wietse ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

Central nervous system; Juvenile dermatomyositis; Vasculitis

Indexed keywords

CREATINE KINASE; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE COURSE; GRAND MAL EPILEPSY; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MUSCLE WEAKNESS; NEUROLOGIC DISEASE; OPHTHALMOLOGY; PRIORITY JOURNAL; RETINA VASCULITIS; RISK FACTOR; SEX DIFFERENCE; SYMPTOMATOLOGY; TREATMENT PLANNING; VASCULAR DISEASE; VISUAL DISORDER; FATALITY; HEMANGIOKERATOMA; HOSPITALIZATION; MAGNETIC RESONANCE ANGIOGRAPHY; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; RISK ASSESSMENT; SEIZURE; VASCULITIS;

ANGIOKERATOMA; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; CHILD, PRESCHOOL; DERMATOMYOSITIS; DISEASE PROGRESSION; FATAL OUTCOME; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; RISK ASSESSMENT; SEIZURES; SEVERITY OF ILLNESS INDEX; VASCULITIS;

EID: 0043195651     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Pachman LM. Juvenile dermatomyositis. Pathophysiology and disease expression. Pediatr Clin North Am 1995;42:1071-98.
2. Bowyer SL, Clark RAF, Ragsdale CG, Hollister JR, Sullivan DB. Juvenile dermatomyositis: histological findings and pathogenetic hypothesis for the associated skin changes. J Rheumatol 1986;13:753-9.
3. van Rossum MAJ, Hiemstra I, Prieur AM, Rijkers GT, Kuis W. Juvenile dermato/polymyositis: a retrospective analysis of 33 cases with special focus on initial CPK levels. Clin Exp Rheumatol 1994;12:339-42.
4. Jimenez C, Rowe PC, Keene D. Cardiac and central nervous system vasculitis in a child with dermatomyositis. J Child Neurol 1994;9:297-300.
5. Gotoff SP, Smith RD, Sugar O. Dermatomyositis with cerebral vasculitis in a patient with agammaglobulinemia. Am J Dis Child 1972;123:53-6.
6. Mozai T. Involvement of the central nervous system in collagen disease. Jpn Circ J 1966;30:1292-9.
7. Hussein A. Juvenile dermatomyositis with respiratory failure and peripheral nerve paralysis. A case report. Klin Padiatr 1987;199:447-8.
8. Ramanan AV, Sawhney S, Murray KJ. Central nervous system complications in two cases of juvenile onset dermatomyositis. Rheumatology 2001;40:1293-8.
9. Calabrese LH, Duna GF, Lie TJ, Vasculitis in the central nervous system. Arthritis Rheum 1997;40:1189-201.
10. Bohan A, Peter JB. Polymyositis and dermatomyositis (parts one and two). N Engl J Med 1975;292:344-7, 403-7.
11. Stone JH, Pomper MG, Roubenoff R, Miller TJ, Hellmann DB. Sensitivities of non-invasive tests for central nervous system vasculitis: a comparison of lumbar puncture, computed tomography and magnetic resonance imaging. J Rheumatol 1994;21:1277-82.
12. Siva A. Vasculitis of the nervous system. J Neurol 2001;248:451-68.
13. Lovblad K, Kelkar P, Ozdoba C, Ramelli G, Remonda L, Schroth G. Pure methotrexate encephalopathy presenting with seizures: CT and MRI features. Pediatr Radiol 1998;28:86-91.
14. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
15. Reed AM, Lopez M. Juvenile dermatomyositis: recognition and treatment. Paediatr Drugs 2002;4:315-21.